You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glycogen Storage Disease Type VI

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glycogen Storage Disease VI, GLYCOGEN STORAGE DISEASE IXa1, GLYCOGEN STORAGE DISEASE IXa2 Trial in Durham (No intervention)

Recruiting
  • Glycogen Storage Disease VI
  • +4 more
  • No intervention
  • Durham, North Carolina
    Duke University
Jul 27, 2022

Biomarker for Glycogen Storage Diseases (BioGlycogen)

Active, not recruiting
  • Fructose Metabolism, Inborn Errors
  • +9 more
    • Rostock, Germany
    • +3 more
    May 12, 2021

    Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis IV A Trial in San Francisco (There is no intervention)

    Recruiting
    • Mucopolysaccharidosis I
    • +7 more
    • There is no intervention
    • San Francisco, California
      University of California San Francisco
    Nov 9, 2022

    MPS I, MPS II, MPS IVA Trial in San Francisco (Aldurazyme (laronidase))

    Recruiting
    • MPS I
    • +8 more
    • Aldurazyme (laronidase)
    • San Francisco, California
      University of California
    Apr 21, 2022

    Biospecimen in Pediatric Patients and Adult Guardians Diagnosed

    Recruiting
    • Glycogen Storage Disease Type IB
    • Specimen Donation
    • Woburn, Massachusetts
      Sanguine BioSciences, Inc.
    Jun 22, 2023

    Pompe Disease, Muscle Loss, Obesity Trial (Multi-ingredient supplement (PDT-MIS), Placebo (PLA))

    Not yet recruiting
    • Pompe Disease
    • +7 more
    • Multi-ingredient supplement (PDT-MIS)
    • Placebo (PLA)
    • (no location specified)
    Nov 8, 2023

    Baby Detect : Genomic Newborn Screening

    Recruiting
    • Congenital Adrenal Hyperplasia
    • +126 more
      • Liege, Wallonia, Belgium
        CRMN, Hôpital La Citadelle
      Jan 24, 2023

      Carbon-13 Magnetic Resonance Spectroscopy in Glycogen Storage

      Recruiting
      • Glycogen Storage Disease
      • +2 more
      • No intervention
      • Copenhagen, Copenhange, Denmark
        Neuromuscular Research Unit, 8077
      Oct 26, 2022

      Pompe Disease -Non-invasive Magnetic Resonance Exploratory Pilot

      Not yet recruiting
      • Pompe Disease
      • McArdle Disease
      • Siemens Magnetom 7T Plus
      • Vienna, Austria
        Medical University of Vienna
      Jul 5, 2023

      Hypoglycemia in Glycogen Storage Disease Type III

      Recruiting
      • Glycogen Storage Disease Type III
      • No Intervention
      • Philadelphia, Pennsylvania
      • +1 more
      Jul 22, 2022

      Pompe Disease, Glycogen Storage Disease Type II (GSD-II), Acid Maltase Deficiency Disease Trial in Gainesville, Decatur, Detroit

      Completed
      Has Results
      • Pompe Disease
      • +2 more
      • alglucosidase alfa
      • Gainesville, Florida
      • +2 more
      Jul 29, 2022

      Glycogen Storage Disease Type IV, Adult Polyglucosan Body Disease Trial in Durham (No intervention)

      Recruiting
      • Glycogen Storage Disease Type IV
      • Adult Polyglucosan Body Disease
      • No intervention
      • Durham, North Carolina
        Duke University Medical Center
      May 20, 2022

      Glycogen Storage Disease Type IB Trial in Shanghai (Empagliflozin)

      Recruiting
      • Glycogen Storage Disease Type IB
      • Shanghai, Shanghai, China
        Xinhua Hospital, Shanghai Jiao Tong University School of Medicin
      Jul 17, 2023

      Adeno-Associated Virus Antibody Study in Subjects OTC

      Recruiting
      • Ornithine Transcarbamylase Deficiency
      • +2 more
        • Akron, Ohio
        • +2 more
        Jul 22, 2022

        Glycogen Storage Disease Type III Trial in Worldwide (biological, other, drug)

        Recruiting
        • Glycogen Storage Disease Type III
        • UX053
        • +4 more
        • Orange, California
        • +9 more
        Jul 22, 2022

        Glycogen Storage Disease Type IA Trial in Groningen ([6,6-2H2]glucose)

        Completed
        • Glycogen Storage Disease Type IA
        • [6,6-2H2]glucose
        • Groningen, Netherlands
          University of Groningen, UMC Groningen
        Feb 10, 2022

        Glycogen Storage Disease Type IA Trial in Worldwide (genetic, other, drug)

        Recruiting
        • Glycogen Storage Disease Type IA
        • DTX401
        • +3 more
        • Orange, California
        • +16 more
        Jan 13, 2023

        Glycogen Storage Disease Trial in United States (mRNA-3745)

        Recruiting
        • Glycogen Storage Disease
        • Farmington, Connecticut
        • +4 more
        Jun 10, 2022

        GSD1 Trial in Worldwide (DTX401)

        Completed
        Has Results
        • GSD1
        • DTX401
        • steroid regimen
        • Farmington, Connecticut
        • +5 more
        Oct 25, 2022

        Pompe Disease (Late-onset) Trial (No Intervention)

        Not yet recruiting
        • Pompe Disease (Late-onset)
        • No Intervention
        • (no location specified)
        Nov 21, 2023

        Glycogen Storage Disease Type I Trial in Durham (Triheptanoin)

        Completed
        • Glycogen Storage Disease Type I
        • Durham, North Carolina
          Duke University Medical Center
        Dec 14, 2021

        Glycogen Storage Disease Type II, Pompe Disease (Late-onset) Trial in Milan (Inspiratory Muscle Training (IMT), Inspiratory

        Recruiting
        • Glycogen Storage Disease Type II
        • Pompe Disease (Late-onset)
        • Inspiratory Muscle Training (IMT)
        • Inspiratory Muscle Training (IMT) + Air Stacking
        • Milan, Italy
          IRCCS S. Maria Nascente - Fondazione Don Carlo Gnocchi
        Jul 11, 2023

        Glycogen Storage Disease Type II Infantile Onset Trial in Gainesville (Cipaglucosidase alfa (ATB200), Miglustat (AT2221))

        Recruiting
        • Glycogen Storage Disease Type II Infantile Onset
        • Gainesville, Florida
          University of Florida Clinical Research Center
        Jan 18, 2023

        Natural History of Pompe Disease

        Recruiting
        • Glycogen Storage Disease Type II, Adult
          • Garches, Hauts-de-Seine, France
            Hôpital Raymond Poincaré
          Apr 20, 2022

          Glycogen Storage Disease Type II Trial in Worldwide (Alglucosidase alfa GZ419829)

          Recruiting
          • Glycogen Storage Disease Type II
          • Alglucosidase alfa GZ419829
          • Leuven, Belgium
          • +8 more
          Jan 17, 2023